Developing a national registry of pharmacologic and biologic clinical trials: workshop report
National Academies Press, Jun 20, 2006 - Medical - 104 pages
14 pages matching Phase in this book
Results 1-3 of 14
What people are saying - Write a review
We haven't found any reviews in the usual places.
How to Write, Publish, & Present in the Health Sciences: A Guide for ...
Thomas A. Lang
Limited preview - 2010
CURRENT REGISTRY ACTIVITIES
CONTENT OF A CLINICAL TRIAL REGISTRY
1 other sections not shown
Other editions - View all
American Medical Association Annals of Internal approved Biogen Idec Biomedical Cancer clinical research clinical trial information clinical trial registry clinical trial results Clinical Trials Data ClinicalTrials.gov compliance data fields Director discussions disease or condition diseases and conditions Drazen Drug Administration Editor-in-Chief Eli Lilly endpoints enrollment Evaluation and Research exploratory trials federal Food and Drug GlaxoSmithKline Health Sciences Policy ICMJE Institute of Medicine Institutes of Health Institutional Review Board Internal Medicine intervention investigational John Hoey Joint Position June 27 Library of Medicine life-threatening diseases Lilly and Company marketed Medical Journal Editors National Academy National Institutes National Library participants patient Pediatrics Perlegen Sciences pharmaceutical industry Phase PhRMA protocol Public Health public trust publicly accessible Section 113 serious or life-threatening sponsor submit information summary trial sites Trials Data Bank University School Vice President workshop World Health Organization